Connect
MJA
MJA

Pharmaceutical preparations

Perspectives

Sodium–glucose cotransporter type 2 inhibitors: managing the small but critical risk of diabetic ketoacidosis

Peter S Hamblin, Rosemary Wong and Leon A Bach

Med J Aust 2020; 212 (7): 294-296.e1

Research

Changes in sales of analgesics to pharmacies after codeine was rescheduled as a prescription only medicine

Andrea L Schaffer, Rose Cairns, Jared A Brown, Natasa Gisev, Nicholas A Buckley and Sallie‐Anne Pearson

Med J Aust 2020; 212 (7): 321-327 Free

Research

Community pharmacy naloxone supply, before and after rescheduling as an over‐the‐counter drug: sales and prescriptions data, 2014–2018

Wai Chung Tse, Paul Sanfilippo, Tina Lam, Paul Dietze and Suzanne Nielsen

Med J Aust 2020; 212 (7): 314-320 Free

Narrative review

Antidepressant‐induced sexual dysfunction

Jody Rothmore

Med J Aust 2020; 212 (7): 329-334

Research letter

Antiplatelet therapy within 30 days of percutaneous coronary intervention with stent implantation

Benjumin Hsu, Michael O Falster, Andrea L Schaffer, Sallie Pearson, Louisa Jorm and David B Brieger

Med J Aust 2020; 213 (3): 124-125 Free

Research

The dispensing of psychotropic medicines to older people before and after they enter residential aged care

Stephanie L Harrison, Janet K Sluggett, Catherine Lang, Craig Whitehead, Maria Crotty, Megan Corlis, Steven L Wesselingh and Maria C Inacio

Med J Aust 2020; 212 (7): 309-313 Free

Letters

Expanding the availability of medications for amyotrophic lateral sclerosis in Australia

Colin J Mahoney and Matthew C Kiernan

Med J Aust 2020; 212 (4): 189-189.e1

Narrative review

Advances in type 2 diabetes therapy: a focus on cardiovascular and renal outcomes

Renata Libianto, Timothy ME Davis and Elif I Ekinci

Med J Aust 2020; 212 (3): 133-139

Letters

Antibiotic use in animals and humans in Australia

Stephen W Page

Med J Aust 2020; 212 (3): 141-141.e1

Letters

Deprescribing needs to be considered in the pharmacists’ prescribing role

Lisa Kouladjian O'Donnell and Mouna J Sawan

Med J Aust 2020; 212 (3): 141-141.e1

Perspectives

Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency

Robert J Commons, James S McCarthy and Ric N Price

Med J Aust 2020; 212 (4): 152-153.e1 Free

Letters

Recognising injuries related to needlestick injury in farmers: the importance of identifying high pressure injections with mineral oil

Jared A Brown, Nicholas A Buckley, Rose Cairns and Claire E Wylie

Med J Aust 2020; 212 (2): 94-94.e1

Letters

Influenza and pertussis vaccination of women during pregnancy in Victoria, 2015–2017

Heidi Shukralla and Michael Coory

Med J Aust 2020; 212 (1): 45-45.e1

Letters

Euglycaemic ketoacidosis from an SGLT2 inhibitor exacerbated by a ketogenic diet

Shampa Sinha, Daniel Gavaghan and Steven Yew

Med J Aust 2020; 212 (1): 46-46.e1

Guideline summary

Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand

Angela L Chiew, David Reith, Adam Pomerleau, Anselm Wong, Katherine Z Isoardi, Jessamine Soderstrom and Nicholas A Buckley

Med J Aust 2020; 212 (4): 175-183

Research letter

Rescheduling codeine‐containing analgesics reduced codeine‐related hospital presentations

Keith Harris, Andrew Jiang, Robert Knoeckel and Katherine Z Isoardi

Med J Aust 2020; 212 (7): 328-328 Free

Letters

Intensive lipid‐lowering therapy in the 12 months after an acute coronary syndrome in Australia: an observational analysis

Simon B Dimmitt and Jennifer H Martin

Med J Aust 2019; 211 (6): 284-284.e1

Letters

Intensive lipid‐lowering therapy in the 12 months after an acute coronary syndrome in Australia: an observational analysis

David B Brieger, James Weaver and Leonard Kritharides

Med J Aust 2019; 211 (6): 285-285.e1

Letters

First reported case of extensively drug‐resistant typhoid in Australia

Annaleise Howard‐Jones, Alison M Kesson, Alexander C Outhred and Philip N Britton

Med J Aust 2019; 211 (6): 286-286.e1

Letters

Regulatory and other responses to the pharmaceutical opioid problem

Thomas Polasek, Melody Caramins and Graeme Suthers

Med J Aust 2019; 211 (5): 237-237.e1

Letters

Regulatory and other responses to the pharmaceutical opioid problem

Gabrielle Campbell, Briony Larance and Nicholas Lintzeris

Med J Aust 2019; 211 (5): 237-237.e1

Letters

Diabetic ketoacidosis with sodium–glucose cotransporter type 2 inhibitors: a case series

Gina McLachlan, Claire Keith and Albert Frauman

Med J Aust 2019; 211 (5): 237-237.e1

Editorials

Paracetamol overdose: limiting the potential for harm

Andis Graudins and Anselm Wong

Med J Aust 2019; 211 (5): 211-212

Research

Paracetamol poisoning‐related hospital admissions and deaths in Australia, 2004–2017

Rose Cairns, Jared A Brown, Claire E Wylie, Andrew H Dawson, Geoffrey K Isbister and Nicholas A Buckley

Med J Aust 2019; 211 (5): 218-223 Free

Medical education / Lessons from practice

Locally acquired extended‐spectrum β‐lactamase Shigella infection

Hui‐Ling Yeoh, Victoria Hall, Deborah A Williamson and Bradley J Gardiner

Med J Aust 2019; 211 (4): 163-164.e1